Correlation Between Decibel Therapeutics and Ideaya Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Decibel Therapeutics and Ideaya Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Decibel Therapeutics and Ideaya Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Decibel Therapeutics and Ideaya Biosciences, you can compare the effects of market volatilities on Decibel Therapeutics and Ideaya Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Decibel Therapeutics with a short position of Ideaya Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Decibel Therapeutics and Ideaya Biosciences.

Diversification Opportunities for Decibel Therapeutics and Ideaya Biosciences

-0.08
  Correlation Coefficient

Good diversification

The 3 months correlation between Decibel and Ideaya is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding Decibel Therapeutics and Ideaya Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ideaya Biosciences and Decibel Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Decibel Therapeutics are associated (or correlated) with Ideaya Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ideaya Biosciences has no effect on the direction of Decibel Therapeutics i.e., Decibel Therapeutics and Ideaya Biosciences go up and down completely randomly.

Pair Corralation between Decibel Therapeutics and Ideaya Biosciences

If you would invest  308.00  in Decibel Therapeutics on October 25, 2024 and sell it today you would earn a total of  0.00  from holding Decibel Therapeutics or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy5.56%
ValuesDaily Returns

Decibel Therapeutics  vs.  Ideaya Biosciences

 Performance 
       Timeline  
Decibel Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Decibel Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Decibel Therapeutics is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
Ideaya Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ideaya Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Decibel Therapeutics and Ideaya Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Decibel Therapeutics and Ideaya Biosciences

The main advantage of trading using opposite Decibel Therapeutics and Ideaya Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Decibel Therapeutics position performs unexpectedly, Ideaya Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ideaya Biosciences will offset losses from the drop in Ideaya Biosciences' long position.
The idea behind Decibel Therapeutics and Ideaya Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
CEOs Directory
Screen CEOs from public companies around the world
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities